PROVENDO
LIVE

Serial Number

90086404

Owner

PROVEPHARM LIFE SOLUTIONS

Attorney

Aaron Y. Silverstein

Filing Date

Jul 31, 2020

Add to watchlist:

No watchlists yet
View on USPTO

PROVENDO Trademark

Serial Number: 90086404 • Registration: 6542386

PROVENDO is a trademark filed by PROVEPHARM LIFE SOLUTIONS on July 31, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

PROVEPHARM LIFE SOLUTIONS (19 trademarks)

22, RUE MARC DONADILLE
MARSEILLE 13013 , FR

Entity Type: 33

Trademark Details

Filing Date

July 31, 2020

Registration Date

November 2, 2021

Published for Opposition

August 17, 2021

Goods & Services

Pharmaceutical preparations in the nature of indigo carmine solutions for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; Chemical preparations in the nature of indigo carmine for medical use for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; Chemical preparations in the nature of indigo carmine solutions for medical use for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; indigo carmine solutions for use as a marker during gastro-intestinal endoscopy; Indigo carmine solutions used as a contrast solution for medical imaging procedures; indigo carmine solutions for medical diagnostic purposes for viewing and marking tissue; indigo carmine solutions used as an aid in visualization of topographic irregularities and in delineation of polypoid or flat lesions, including adenomas; indigo carmine solutions used for polyps or lesions resection medicines for tissue staining; indigo carmine solutions for use as a marker during visceral surgery; indigo carmine solutions for the detection of amniotic fluid leaks; indigo carmine solutions for use as a marker during cystoscopy and ureteral catheterization; indigo carmine solutions for use as a marker during vessel delineation and tumor localization procedures; clinical medical reagents; synthetic peptides for pharmaceutical use, namely, for cancer treatments, immunotherapy, cell therapy, antivirals and antibiotics; phytotherapy preparations for medical use; diagnostic preparations in vials for medical use; Drug delivery agents in the form of vials filled with indigo carmine solutions that facilitate the delivery of pharmaceutical preparations; pre-filled syringes for medical and clinical purposes, sold filled with indigo carmine solutions for marking tissue by injection application in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable, for the antiseptic treatment orally or topically, for marking and functional verification gynecological and urological systems, by instillation, injection or local application; all of these goods excluding food supplements, hand sanitizing preparations, insect repellents and bone growth media

Medical apparatus and instruments for use in exploratory endoscopy procedures in surgery, gynecology, urology, gastroenterology and medical imaging procedures; apparatus and instruments for diagnostic purposes for medical use for use in surgery, gynecology, urology and gastroenterology procedures

Filing History

REGISTERED-PRINCIPAL REGISTER
Nov 2, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 17, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 17, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 28, 2021 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jul 8, 2021 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jul 2, 2021 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 26, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 25, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 25, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 10, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jun 10, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jun 10, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 20, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 20, 2021 CRFA
ASSIGNED TO LIE
May 20, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 12, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 20, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 20, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 20, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 19, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 1, 2020 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Aug 31, 2020 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 31, 2020 PARI
NEW APPLICATION ENTERED
Aug 4, 2020 NWAP